top of page
tokers-guide-find-the-best-weed-in-dc-lo
NEW 1 to 1 photo editing 122024 (17).png
Louisiana senators approved a bill to create a psychedelic-assisted therapy pilot program funded by opioid settlement dollars for clinical trials on substances like psilocybin and ibogaine. The program would be overseen by the state health department and includes revenue-sharing provisions for the state if new treatments are developed.

Louisiana Lawmakers Greenlight New Psychedelic Therapy Trials Using Opioid Settlement Funds

Mar 26, 2026

Source:

Kyle Jaeger

Marijuana Moment

Louisiana is taking a bold step into the future of medicine, as state senators recently greenlit a plan to explore the healing power of psychedelics. This isn't just talk; they’ve approved a bill to launch a clinical trial program focusing on breakthrough treatments like psilocybin and ibogaine. What makes this move even more interesting is the funding source: the state is tapping into opioid settlement funds to pay for it. It’s a poetic bit of justice, using money from the crisis that harmed so many to find innovative ways to help people heal.

The push for this legislation, led by Senator Patrick McMath, was heavily inspired by the stories of military veterans. Many former service members have found profound relief through psychedelic-assisted therapy when traditional methods failed them. If the program yields a successful new medication, the state even has a plan to share in the profits, ensuring that a portion of the revenue goes back into public coffers.

This news is a massive win for the broader plant-medicine community. While the focus is currently on clinical settings for those struggling with opioid addiction or treatment-resistant mental health issues, it signals a major shift in how the South views alternative therapies. For regular tokers and wellness seekers, this progress helps normalize the conversation around substances that have been misunderstood for decades.

If you’re a Louisianan interested in these developments, keep an eye on the state's Department of Health, which will oversee the trials. While we aren't at the point of retail access, this pilot program puts Louisiana in a national consortium for drug development, aligning them with similar efforts in places like Texas. For those looking for immediate natural relief, the state’s medical marijuana program remains the primary legal avenue, but the horizon for therapeutic options is definitely expanding. It’s a great time to stay informed and advocate for wider accessibility as these "innovative medicines" prove their worth. Stay tuned—the Pelican State might just become a leader in the next wave of the wellness revolution.

Recent Reviews

bottom of page